Cargando…

Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study

OBJECTIVES: In the absence of widely accepted criteria, determining when a patient with Parkinson's disease (PD) may benefit from more advanced treatments such as device‐aided therapy (DAT) so far remains a matter of physician judgment. This analysis investigates how classification of PD varies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fasano, Alfonso, Fung, Victor S. C., Seppi, Klaus, Pirtosek, Zvezdan, Takáts, Annamária, Alobaidi, Ali, Onuk, Koray, Bergmann, Lars, Parra, Juan Carlos, Elibol, Bulent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541702/ https://www.ncbi.nlm.nih.gov/pubmed/35607843 http://dx.doi.org/10.1111/ane.13648

Ejemplares similares

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
por: Fasano, Alfonso, et al.
Publicado: (2019)

Characterizing Advanced Parkinson's Disease: Romanian Subanalysis from the OBSERVE-PD Study
por: Szasz, Jozsef Attila, et al.
Publicado: (2021)

Characterization of advanced Parkinson’s disease in Germany: results of the non-interventional OBSERVE-PD study
por: Pedrosa, David J., et al.
Publicado: (2022)

Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study
por: Stefani, Alessandro, et al.
Publicado: (2022)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020)

Causes of Sickness Absenteeism in Europe—Analysis from an Intercountry and Gender Perspective
por: Antczak, Elżbieta, et al.
Publicado: (2021)

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study
por: Evans, Andrew, et al.
Publicado: (2020)

Variability of Greenhouse Gas Footprints of Field Tomatoes Grown for Processing: Interyear and Intercountry Assessment
por: Lam, Wan Yee, et al.
Publicado: (2017)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Wavelet Analysis Increases Sensitivity and Specificity of Spirography for Ambulatory Tremor Discrimination
por: Kragelj, Veronika, et al.
Publicado: (2014)

Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra
por: Zupan, Gašper, et al.
Publicado: (2019)

An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients
por: Krüger, Rejko, et al.
Publicado: (2017)

Southeast Asia intercountry consultative meeting on prevention and control of new, emerging, and reemerging infectious diseases.
por: Plianbangchang, S
Publicado: (1995)

Headache Because of Problems with Teeth, Mouth, Jaws, or Dentures in Chronic Temporomandibular Disorder Patients: A Case–Control Study
por: Ostrc, Tadej, et al.
Publicado: (2022)

Detecting Subtle Cognitive Impairment in Patients with Parkinson’s Disease and Normal Cognition: A Novel Cognitive Control Challenge Task (C3T)
por: Resnik Robida, Karmen, et al.
Publicado: (2023)

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Infectious Diseases in Internationally Adopted Children and Intercountry Discrepancies Among Screening Protocols, A Narrative Review
por: Chiappini, Elena, et al.
Publicado: (2019)

Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
por: Antonini, Angelo, et al.
Publicado: (2022)

The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel
por: Pedersen, Stephen W, et al.
Publicado: (2017)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Odin, Per, et al.
Publicado: (2018)

Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
por: Fasano, Alfonso, et al.
Publicado: (2023)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Temporal trends and socioeconomic differences in acute respiratory infection hospitalisations in children: an intercountry comparison of birth cohort studies in Western Australia, England and Scotland
por: Moore, Hannah C, et al.
Publicado: (2019)

Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)
por: Schneider, Ruth B., et al.
Publicado: (2020)

Human Gait Activity Recognition Machine Learning Methods
por: Slemenšek, Jan, et al.
Publicado: (2023)

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
por: Malaty, Irene A., et al.
Publicado: (2022)

A multicenter study of genetic testing for Parkinson’s disease in the clinical setting
por: Kovanda, Anja, et al.
Publicado: (2022)

Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
por: Esterhammer, Regina, et al.
Publicado: (2015)

Sensorimotor integration training in Parkinson’s disease
por: Fil-Balkan, Ayla, et al.
Publicado: (2018)

Correction: Temporal trends and socioeconomic differences in acute respiratory infection hospitalisations in children: an intercountry comparison of birth cohort studies in Western Australia, England and Scotland
Publicado: (2020)

Towards seeing the visual impairments in Parkinson’s disease: protocol for a multicentre observational, cross-sectional study
por: Borm, Carlijn D. J. M., et al.
Publicado: (2019)

Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study
por: Rus, Tomaž, et al.
Publicado: (2022)

Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey
por: Morita, Tatsuya, et al.
Publicado: (2022)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari, Szabolcs, et al.
Publicado: (2017)

Punding in Parkinson's Disease: An Update
por: Rajalingam, Rajasumi, et al.
Publicado: (2023)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l7dl9kn2kgsilnnqmdbl2de0lo